您要查找的是不是：
- 聯(lián)合檢測ARPA與抗Sm抗體和抗dsDNA抗體,可以提高血清學(xué)診斷SLE的檢出率。It can enhance the diagnostic rate of SLE by the determination of combining the ARPA with anti-dsDNA and anti-Sm anti-bodies.
- 結果顯示TCV可明顯地抑制CJ-S131誘導的特異性遲發(fā)型超敏反應,相反卻顯著(zhù)地增強抗dsDNA抗體和抗外膜蛋白抗體生成。The results sho wed that TCV is unable to cure or prevent SLE-like syndrome. Although the delayed type hypcrsensitivity against CJ-S131 was significantly inhibited, TCV markedly enhanced the anti-dsDNA antibody and membrane protein of CJ-S131 antibody production.
- SLE患者治療前后T細胞表面Fas/T與SLE疾病活動(dòng)指數(SLEDAI)之間,具有明顯的相關(guān)性(P<0.05),治療前后T細胞表面Fas/T與抗dsDNA抗體、C3和C4之間無(wú)明顯的相關(guān)性(P>0.05)。Along with the decrease in disease activity of active SLE patients, there was a positive correlation be- tween SLEDAI and Fas receptor molecules on T lymphocytes before and after treatment(P<0.05), while the later had no correlation with anti- dsDNA antibody and C3, C4 complements level (P>0.05).
- 抗dsDNA自身抗體anti-dsDNA autoantibody
- 紅斑狼瘡(SLE和DLE)抗核抗體、抗ENA抗體和抗dsDNA抗體的檢測及意義Detection of ANA,anti-ENA antibodies and anti-dsDNA antibodies in lupus erythematosus
- 目的研究CpG序列在誘生抗dsDNA抗體中的作用及可能機制。Objective To investigate the effect of CpG sequences on t he induction of anti-dsDNA antibodies and the possible mechanism.
- SLE患者組AnuA與抗-Sm抗體之間無(wú)相關(guān)性(P>0.05),但與抗-dsDNA抗體顯著(zhù)相關(guān)(P<0.01),聯(lián)合檢測AnuA、抗-dsDNA抗體、抗-Sm抗體診斷SLE的敏感性達76.7%;There was no correlation between AnuA and anti-Sm in SLE group(P>0.05),while there was significant correlation between AnuA and anti-dsD-NAinSLEgroup(P<0.01). ThepositiverateofcombiningAnuAandanti-dsDNAaswellasanti-SmforSLEwas76.7%25.
- 抗衰anti-ageing; senile-resistant
- ARPA的表達與抗SSA、抗SSB和抗nRNP抗體表達相關(guān)(P<0.05),而與ANA、抗dsDNA和抗sm抗體的相關(guān)性不強(P>0.05)。The expression of ARPA was correlated to anti-SSA, anti-SSB, anti-nRNP, but not to ANA anti-dsDNA and anti-sm.
- 抗CD3抗體anti-CD3 antibody
- 抗Clq抗體anti-Clq antibody
- 抗E2抗體anti-E2 antibody
- 抗FSH抗體anti-FSH-antibody
- 抗GST抗體anti-GST antibody
- 抗TNF抗體anti-TNF
- 抗雞抗體anti-chicken antibody
- 抗毒抗體antibody against toxin
- 抗-HBe抗體anti - HBe anntibody
- 抗LKM-1抗體anti- LKM- 1 antibody
- 抗CCP2抗體anti-CCP2 antibody
